Creative Medical Technology Holdings, a Phoenix, Arizona firm, has filed for a patent for its AmnioStem amniotic fluid derived stem cell therapy for treatment of stroke. According to the company, “The patent application covers the use of the Company’s newly licensed AmnioStem stem cell as a production means for generation of nanoparticles termed “exosomes,” which regenerate damaged brain tissue after stroke.”
Technology info page: AmnioStem…
Read on at Creative Medical Technology: Collaboration between Stem Cell Clinician, Neurologist, and Cell Therapy Developer Results in Novel Regenerative Approach to Stroke…